Log in to save to my catalogue

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7595123

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease

About this item

Full title

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2020-10, Vol.11 (10), p.927, Article 927

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Iron accumulation in the substantia nigra is recognized as a hallmark of Parkinson’s disease (PD). Therefore, reducing accumulated iron and associated oxidative stress is considered a promising therapeutic strategy for PD. However, current iron chelators have poor membrane permeability and lack cell-type specificity. Here we identified GSK-J4, a hi...

Alternative Titles

Full title

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7595123

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7595123

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-020-03105-5

How to access this item